The report provides a detailed analysis essential for establishing a Dichlorphenamide production plant. It encompasses all critical aspects necessary for Dichlorphenamide production, including the cost of Dichlorphenamide production, Dichlorphenamide plant cost, Dichlorphenamide production costs, and the overall Dichlorphenamide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Dichlorphenamide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Dichlorphenamide is a medication used to reduce intraocular pressure, primarily in some types of glaucoma, a disease that affects the optic nerve of the eye and can cause vision loss. It is a member of the class of drugs called carbonic anhydrase inhibitors. This medicine is normally used in the treatment of open-angle glaucoma and secondary glaucoma and for controlling acute angle-closure glaucoma, especially when the surgery is warranted but cannot be done immediately. It decreases pressure in the eye and thus helps control vision and the overall health of the eyes. Furthermore, it is also used in the treatment of in the treatment of inherited muscle disorders, such as primary hyperkalemic periodic paralysis and related variants.
The market for Dichlorphenamide is driven by its application as a carbonic anhydrase inhibitor to treat various types of glaucoma, which significantly increases its demand in the pharmaceutical and medical industries. The rising cases of glaucoma are significantly increasing the demand for Dichlorphenamide. Additionally, the drug’s ability to be utilized in different types of glaucoma, such as open-angle glaucoma and secondary glaucoma, and for controlling acute angle-closure glaucoma, especially when the surgery is warranted but cannot be done immediately, amplifies its market presence.
Moreover, it is also known to be employed in the treatment of inherited muscle disorders, such as primary hyperkalemic periodic paralysis and related variants, thereby contributing to its market growth. Overall, industrial Dichlorphenamide procurement is influenced by its application in the pharmaceutical and medical industries, rising cases of glaucoma, its ability to be utilized in various types of glaucoma, employment to treat several muscle disorders, and regulatory approvals.
Raw Material for Dichlorphenamide Production
According to the Dichlorphenamide production plant project report, the key raw material used in the production of Dichlorphenamide includes 2-chlorophenol.
Production Process of Dichlorphenamide
The extensive Dichlorphenamide production cost report consists of the following major industrial production process:
- Production from 2-chlorophenol: The production process of Dichlorphenamide starts with the sulfochlorination of 2-chlorophenol by chlorosulfonic acid to form 4-hydroxy-5-chlorobenzol-1,3-disulfonylchloride. The hydroxyl group of the resulting compound is replaced by a chlorine atom by using phosphorous pentachloride to give 4,5-dichlorobenzol-1,3-disulfonylchoride. Finally, the compound is reacted with ammonia to produce the desired Dichlorphenamide.
Dichlorphenamide, commercially known as KEVEYIS, is a white crystalline compound with a characteristic odor, having the molecular formula C6H6Cl2N2O4S2 and a molecular weight of 305.2 g/mol. It has a melting point of around 228.5 °C. It is almost insoluble in water, with an estimated water solubility of 0.398 mg/mL, but dissolves in alkaline solution, pyridine, alcohol, and sodium carbonate. It is also soluble to some extent in ether. It has a log P value of 0.2. The value of its dissociation constant, pKa, is 7.4.
